prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
TERBUTALINE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
DIGITOXIN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
BETAHISTINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BETAHISTINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
TERBUTALINE |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
TERBUTALINE |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
synaptic vesicle glycoprotein 2b |
TAMOXIFEN |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
NETILMICIN |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
STREPTOMYCIN |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
AMIODARONE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 2 |
TANNIC ACID |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) |
TANNIC ACID |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
natriuretic peptide receptor 3 |
TANNIC ACID |
Atrial Natriuretic Factor (ANF) |
-20% |
NoneNone |
NoneNone |
View
|
arginine vasopressin receptor 1A |
TANNIC ACID |
Vasopressin V1A |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
TANNIC ACID |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TANNIC ACID |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
U-78517F |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
U-78517F |
Monoamine Oxidase MAOA |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
CHLORAMPHENICOL |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
CHLORAMPHENICOL |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
AMLODIPINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
AMLODIPINE |
Bradykinin B2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
STANNOUS FLUORIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
STANNOUS FLUORIDE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
TANNIC ACID |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
U-78517F |
Neuropeptide Y1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
CHLORAMPHENICOL |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
CHLORAMPHENICOL |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
AMOXAPINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
angiotensin II receptor, type 2 |
ISONIAZID |
Angiotensin AT2 |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CLOTRIMAZOLE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
CLOTRIMAZOLE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 3 |
CHLOROXYLENOL |
Adrenergic beta3 |
-20% |
NoneNone |
NoneNone |
View
|
histamine receptor H 2 |
CHLOROXYLENOL |
Histamine H2 |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
TANNIC ACID |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
TANNIC ACID |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
IBUPROFEN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
IBUPROFEN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
IBUPROFEN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
IBUPROFEN |
Glutamate, AMPA |
-20% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
IBUPROFEN |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
ISONIAZID |
Serotonin 5-HT2B |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3B |
SULINDAC |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
phosphodiesterase 3A |
SULINDAC |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
SULINDAC |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
tumor necrosis factor receptor superfamily, member 8 |
NOCODAZOLE |
Tumor Necrosis Factor (TNF), Non-Selective |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 |
LACTIC ACID |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
LACTIC ACID |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
4-OCTYLPHENOL |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
BIS(2-ETHYLHEXYL)PHTHALATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
BIS(2-ETHYLHEXYL)PHTHALATE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
MESTRANOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 3 |
LIPOPOLYSACCHARIDE E. COLI O55:B5 |
Muscarinic M3 |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
MESTRANOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
MESTRANOL |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 1 |
4-OCTYLPHENOL |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X, ligand-gated ion channel, 7 |
4-OCTYLPHENOL |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
purinergic receptor P2X-like 1, orphan receptor |
4-OCTYLPHENOL |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
ATRACTYLOSIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
ATRACTYLOSIDE |
Protein Serine/Threonine Kinase PKCalpha |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
4-OCTYLPHENOL |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
4-OCTYLPHENOL |
Serotonin 5-HT3 |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
BACITRACIN |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
melanocortin 4 receptor |
ALPRAZOLAM |
Melanocortin MC4 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 5B |
ATRACTYLOSIDE |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 4 |
ATRACTYLOSIDE |
Serotonin 5-HT4 |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, beta 1 |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, mu |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, iota |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, zeta |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, delta |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase D1 |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, theta |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, epsilon |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
protein kinase C, gamma |
BACITRACIN |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
BETA-ESTRADIOL |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
TOLNAFTATE |
GABAA, Benzodiazepine, Central |
-20% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
TICLOPIDINE |
Chemokine CCR4 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 1 subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1E subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, N type, alpha 1B subunit |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha2/delta subunit 1 |
CROTAMITON |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
FLUOCINONIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
FLUOCINONIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
FLUOCINONIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
FLUOCINONIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
FLUOCINONIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
FLUOCINONIDE |
Glutamate, NMDA, Phencyclidine |
-20% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 3 |
FLUPHENAZINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 3 |
FLUPHENAZINE |
Protein Serine/Threonine Kinase, ERK1 |
-20% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, alpha 2a |
D-CAMPHOR |
Adrenergic alpha2A |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, gamma |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, delta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type X, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage gated, type VIII, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
D-CAMPHOR |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) |
NETILMICIN |
Thromboxane Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
DIGITOXIN |
Serotonin 5-HT2B |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
DIHYDROERGOTAMINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
DIHYDROERGOTAMINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
NETILMICIN |
Calcium Channel Type L, Phenylalkylamine |
-20% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 |
SULFADOXINE |
Serotonin Transporter |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 1 (interstitial collagenase) |
AMPICILLIN |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
NEOMYCIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
NEOMYCIN |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-20% |
NoneNone |
NoneNone |
View
|
opioid receptor, sigma 1 |
AMPICILLIN |
Sigma1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 |
NEOMYCIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
NEOMYCIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
interleukin 1 receptor, type I |
AMPICILLIN |
Interleukin IL-1 alpha |
-20% |
NoneNone |
NoneNone |
View
|
cannabinoid receptor 1 (brain) |
NEOMYCIN |
Cannabinoid CB1 |
-20% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
URETHANE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|